Already this year cancer patients at certain European hospitals will benefit from the introduction of the Functional Precision Medicine (FPM) test, IndiTreat®. The test makes it possible to match a cancer patient with the most effective drug treatment.
https://www.businessinsights.dk/wp-content/uploads/2020/03/51.jpg450760kristofferlohse76https://www.businessinsights.dk/wp-content/uploads/2018/10/Logo_Businessinsights_2.jpgkristofferlohse762020-04-01 11:11:152020-04-01 13:24:03The Danish Biotech Company, 2curex Will Make Individual Cancer Treatment a Reality for European Patients in 2020